RGEN:NASDAQ
Repligen Corp
$183.44
arrow_upward
+0.95%(+1.74) 1D
Oct 5, 12:30:34 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RGEN...
Open
$178.75
High
$185.00
Low
$178.61
Mkt. cap
10.35B
Avg. vol.
1.08M
Volume
193.06K
P/E ratio
250.04
52-wk high
$198.87
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
56.44M
No. of employees
2K
Open
$178.75
High
$185.00
Low
$178.61
Mkt. cap
10.35B
Avg. vol.
1.08M
Volume
193.06K
P/E ratio
250.04
52-wk high
$198.87
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
56.44M
No. of employees
2K
News stories
From web sources and news partners
Stock Traders Daily
·
2 days ago
How (RGEN) Movements Inform Risk Allocation Models
Stocktwits
·
6 days ago
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs?
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2K
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websiterepligen.com